BDNF + Neuroprotection Research — for in-vitro research and laboratory use only

Neurotrophic (Semax + BPC-157)

Neuropeptide and pentadecapeptide co-investigated in neuroprotection research.

Semax is a heptapeptide ACTH-fragment analogue studied for BDNF and NGF pathway effects. BPC-157 has a smaller but growing body of preclinical neuroprotection-research literature. Researchers pair them in CNS-research study designs that probe neurotrophic-axis modulation versus tissue-protection-axis modulation in the same experimental run.

All research stacks · Research hub · Certificates of Analysis

For research use only. Not for human consumption.